MIAMI, FL--(Marketwire - March 03, 2008) - OncoMune LLC announced positive results demonstrating that the genetic inhibition of BORIS expression leads to programmed cell death of cancer cells. The results will be presented at the upcoming American Association of Cancer Researchers (AACR) Annual Meeting in San Diego, April 12-16 by Dr. Christopher Dougherty, Research Assistant Professor of Biomedical Science at Florida Atlantic University in collaboration with OncoMune.
